Stock Updates

Today’s Top Gainers in the Market Boston Scientific Corporation (NYSE:BSX) from Healthcare

Today’s top gainers include the company Boston Scientific Corporation (NYSE:BSX) which is in the industry Medical Appliances & Equipment, gaining 1.24% today. In the last week its performance is 1.15%, and 0.55% for the past quarter. Currently, Boston Scientific Corporation, BSX has a target price of *TBA, so today’s gain of 1.24% is a significant step towards its target price. The GAP today is therefore 0.60%.

Boston Scientific Corporation (NYSE:BSX), has a market cap of 32345.03, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 94.00%.

At the current price of 23.77, it has a dividend yield of *TBA, and its target price is *TBA. This is with a profit margin of -4.30%, and total debt/equity of 0.87. Boston Scientific Corporation (NYSE:BSX) has a P/E of *TBA, as well as a forward P/E of 18.81.

With a current EPS of -0.26, and a forecasted EPS growth for next year at 14.80%,Boston Scientific Corporation (NYSE:BSX) has had a EPS growth for the past five years at 24.00%. For the next five years EPS growth is projected to be 11.83%.

Performance for the year is 40.82%. Since its IPO date on 5/19/1992, the total performance to date is 28.90%.

Volume today for Boston Scientific Corporation (NYSE:BSX), is 4034900, while its average volume is 7744.08. Whilst the total gain today was 1.24%, it did have a day high of -3.84%.

Volatility for this week has been at 1.35%, and 1.79% for the month. The 52-week low for Boston Scientific Corporation, BSX has been 51.69%, while the 52-week-high has reached -4.11%.

Looking at its return of investments, which is 0.70%, and its return on assets is -1.90%. Boston Scientific Corporation (NYSE:BSX) has an operating margin of -7.70%. With a sales growth of 15.40% quarter over quarter. Bearing in mind that Boston Scientific Corporation, BSX is in the sector Healthcare, its long-term debt/equity is 0.83, and has a current ratio of 1 and 0.7 for quick ratio.

So what is the value of Boston Scientific Corporation? Well its PEG is *TBA, and the P/S is 4.07, along with a P/B of 5.19. Meanwhile it has a p/cash of 73.85.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment